Trials of the HIV-1 vaccine have been conducted in Europe, North America, Brazil, China, and Thailand. The first trial of a candidate vaccine in Africa was recently completed in Uganda. It involved a randomised, placebo controlled trial of a vaccine in healthy volunteers at low risk of HIV infection. 3 The vaccine, called “ALVAC-HIV,” uses a live recombinant canarypox vector to express envelope...